A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez
Clinical trial NCT06423573 · RECRUITING
Trial details
- NCT number
- NCT06423573
- Sponsor
- Amryt Pharma
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-12-18
- Primary completion
- 2031-11-30
- Enrollment
- 580
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.